Check proposals against policy, evidence, and decision rights before anything moves.
SigmaX provides capital decision intelligence, scenario analysis, and authority workflow software. SigmaX does not provide investment advice. SigmaX does not place trades, move funds, route customer capital, or manage client capital. Shadow/simulated/paper/backtested results are not live trading results. No result is a guarantee of future performance. Human approval is required before any capital-linked action.
Where SigmaX uses AI, it is governed as assistive software: truthful capability claims, human oversight, traceable records, disclosure of AI assistance, and no capital authority. SigmaX designs AI controls with reference to applicable securities obligations, FINRA existing-rule guidance, SEC AI-claims discipline, NIST AI RMF-style risk management, and EU AI Act transparency readiness. This is compliance-readiness design, not a claim that every deployment or jurisdiction-specific use has completed legal review.
SigmaX does not guarantee returns. Market participation involves risk, including possible loss of capital. Certain capabilities remain in private validation or development. The current SigmaX surface is read-only and operator-supervised; no live capital authority is granted by AI or by the client portal. Any capital-linked participation, execution authority, or allocation structure remains subject to suitability, legal, compliance, and capital-governance review.
Patent pending. Technology underlying AIgenTXS and SigmaX is the subject of multiple pending United States patent applications. No patent has been granted.
© 2026 SigmaX Capital LLC. All rights reserved. U.S. patent pending.
Evidence before action.
